NextCure (NXTC) Short Interest
Nasdaq • NXTC • US65343E2072
As of Oct 27, 2026, ORTEX estimated 5.5% of free float sold short, 2.3 days to cover, cost to borrow 98.63%. Sign up for live short interest data.
Nasdaq • NXTC • US65343E2072
As of Oct 27, 2026, ORTEX estimated 5.5% of free float sold short, 2.3 days to cover, cost to borrow 98.63%. Sign up for live short interest data.
This page tracks how heavily NextCure (Nasdaq:NXTC) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
NextCure (Nasdaq: NXTC) has a market capitalization of $27.37M. Last close $5.98 (as of 2026-11-12); 52-week range $1.55 to $15.74. ORTEX data as of 2026-10-27: short interest was 5.45% of free float, 2.3 days to cover and the average cost to borrow was 98.63%. Sign up for live short interest data.